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Abstract	  
Myokine	  is	  a	  term	  referring	  to	  a	  variety	  of	  cytokines	  or	  chemokines	  that	  are	  produced	  and	  
released	  by	  myocytes	  in	  response	  to	  skeletal	  muscle	  contractions.	  The	  myokine	  response	  to	  
prolonged	  exercise	  is	  not	  well	  known.	  Therefore,	  the	  purpose	  of	  this	  study	  was	  to	  investigate	  
the	  myokine	  response	  to	  prolonged	  exercise	  by	  measuring	  fifteen	  different	  myokines	  in	  skeletal	  
muscle	  biopsies.	  Trained	  cyclists	  (N=14)	  participated	  in	  a	  75-­‐km	  cycling	  time	  trial,	  with	  muscle	  
samples	  from	  the	  vastus	  lateralis	  taken	  before	  and	  after	  the	  exercise	  bout.	  The	  skeletal	  muscle	  
biopsy	  samples	  were	  analyzed	  for	  15	  myokines	  including:	  APLN,	  CX3CL1,	  BDNF,	  EPO,	  SPARC,	  LIF,	  
IL15,	  GDF8,	  FABP3,	  Irisin,	  FSTL1,	  OSM,	  IL6,	  FGF21,	  and	  OSTN.	  These	  myokines	  were	  analyzed	  
with	  a	  magnetic	  bead-­‐based	  multiplex	  assay.	  The	  75km	  cycling	  exercise	  bout	  significantly	  
increased	  skeletal	  muscle	  Interleukin-­‐15,	  Oncostatin	  M,	  and	  Fractalkine	  protein	  levels	  from,	  
0.043±0.008	  to	  0.055±0.021,	  0.0014±0.002	  to	  0.0059±0.004	  and	  4.45±0.46	  to	  4.60±0.54	  pg/µg,	  
respectively	  (all	  p<0.05).	  Apelin	  protein	  levels	  exhibited	  a	  decrease	  from	  3.95±1.18	  to	  3.33±1.21	  
pg/µg	  (p<0.05).	  No	  statistically	  significant	  difference	  was	  observed	  for	  FSTL1,	  IL6,	  SPARC,	  BDNF,	  
FGF21,	  LIF,	  or	  OSTN.	  Erythropoietin,	  Irisin,	  and	  Myostatin	  were	  all	  below	  detectable	  limits	  for	  
the	  assay,	  and	  Fatty	  Acid-­‐Binding	  Protein	  3	  exhibited	  values	  above	  the	  detection	  limit.	  Over	  the	  
last	  couple	  decades,	  our	  knowledge	  of	  cytokine	  proteins	  has	  increased	  considerably	  as	  has	  our	  
understanding	  of	  their	  functions	  and	  regulatory	  mechanisms.	  However,	  with	  few	  exceptions,	  
our	  knowledge	  is	  still	  relatively	  limited	  as	  to	  the	  mechanism	  and	  regulation	  of	  cytokine	  
production	  during	  exercise,	  especially	  in	  the	  muscle	  tissue.	  Consequently,	  research	  is	  still	  
ongoing	  for	  many	  of	  the	  tested	  proteins	  to	  determine	  their	  function	  when	  it	  comes	  to	  skeletal	  
muscle	  adaptation.	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Introduction	  
Cytokines	  are	  small	  proteins	  produced	  by	  cells	  with	  functions	  typically	  specific	  to	  the	  
immune	  system.	  The	  immune	  response	  is	  generally	  accomplished	  through	  chemotaxis	  of	  
inflammatory	  cytokines.	  A	  subgroup	  of	  cytokines,	  called	  chemokines,	  function	  to	  attract	  cells	  to	  
the	  sites	  of	  inflammation	  or	  infection.	  More	  specifically,	  chemokines	  typically	  direct	  the	  
migration	  of	  leukocytes	  to	  an	  area	  of	  infection20	  or	  damaged	  tissue.	  Cytokine	  release	  during	  
exercise	  has	  a	  role	  in	  many	  physiological	  processes	  including	  immune	  cell	  recruitment,	  
inflammation,	  lipolysis	  stimulation,	  and	  tissue	  repair.	  	  
Myokine	  is	  a	  term	  referring	  to	  a	  variety	  of	  cytokines	  or	  chemokines	  that	  are	  produced	  
and	  released	  by	  myocytes	  in	  response	  to	  skeletal	  muscle	  contractions	  (i.e.	  exercise).	  The	  
discovery	  of	  specific	  myokines	  has	  only	  recently	  been	  described	  in	  the	  literature.	  Of	  what	  little	  
published	  research	  is	  available,	  it	  suggests	  that	  the	  myokine	  response	  varies	  between	  
individuals,	  and	  may	  differ	  depending	  on	  a	  variety	  of	  factors	  that	  may	  include	  mode,	  type,	  
intensity,	  or	  duration	  of	  exercise,	  gender,	  medications,	  and	  fitness	  condition.5	  The	  myokine	  
response	  to	  prolonged	  exercise	  is	  not	  well	  known.	  Therefore,	  the	  purpose	  of	  this	  study	  was	  to	  
investigate	  the	  myokine	  response	  to	  prolonged	  exercise	  by	  measuring	  fifteen	  different	  
myokines	  in	  skeletal	  muscle	  biopsies	  of	  trained	  cyclists	  before	  and	  after	  75	  km	  of	  cycling.	  
	  
Overview	  of	  specific	  myokines	  measured	  
Apelin	  
Apelin	  is	  encoded	  by	  the	  APLN	  gene	  and	  is	  expressed	  in	  vital	  organs	  such	  as	  the	  heart,	  
lungs,	  kidneys,	  and	  liver.	  It	  is	  also	  present	  in	  fatty	  tissue,	  the	  GI	  tract,	  and	  blood	  plasma.	  Apelin	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may	  exist	  in	  a	  variety	  of	  amino	  acid	  lengths,	  as	  the	  APLN	  gene	  encodes	  an	  original	  protein	  of	  77	  
amino	  acids.21	  After	  various	  cleavage	  mechanisms,	  the	  initial	  proprotein	  may	  give	  rise	  to	  several	  
active	  fragments.	  One	  type	  of	  expression	  of	  Apelin	  is	  in	  the	  vasculature	  as	  it	  participates	  in	  the	  
control	  of	  blood	  pressure	  as	  angiogenesis	  is	  stimulated	  by	  its	  activation.	  This	  results	  in	  the	  
lowering	  of	  mean	  arterial	  pressure	  through	  the	  means	  of	  a	  nitric	  oxide	  dependent	  mechanism,	  
which	  acts	  as	  a	  powerful	  vasodilator.27	  In	  the	  cardiac	  system,	  Apelin	  has	  been	  described	  as	  one	  
of	  the	  most	  potent	  stimulators	  of	  cardiac	  contractility.21	  Perhaps	  acting	  as	  a	  compensatory	  
measure,	  Apelin	  levels	  have	  been	  shown	  to	  be	  elevated	  in	  obese	  individuals	  and	  patients	  with	  
chronic	  heart	  failure.21,	  23	  Several	  functions	  are	  exhibited	  in	  the	  digestive	  system	  as	  well.	  In	  the	  
pancreas,	  increased	  levels	  of	  Apelin	  result	  in	  the	  inhibition	  of	  insulin	  secretion,	  revealing	  an	  
interdependence	  between	  insulin	  production	  and	  the	  introduction	  of	  Apelin	  through	  a	  signaling	  
system.	  Acid	  secretion	  of	  parietal	  cells	  is	  also	  repressed	  by	  the	  inhibition	  of	  histamine	  release	  
within	  the	  stomach	  lining.23,27	  There	  is	  little	  known	  about	  the	  role	  of	  Apelin	  in	  the	  skeletal	  
muscle,	  but	  recent	  research	  suggests	  that	  it	  plays	  a	  role	  in	  glucose	  uptake	  in	  skeletal	  muscle	  
cells.	  
	  
Brain-­‐Derived	  Neurotrophic	  Factor	  
Brain-­‐derived	  neurotrophic	  factor	  (BDNF)	  is	  a	  growth	  factor	  protein	  encoded	  by	  the	  
BDNF	  gene.	  BDNF	  is	  especially	  useful	  in	  the	  central	  and	  peripheral	  nervous	  system,	  as	  it	  
encourages	  the	  growth	  of	  new	  neurons	  while	  promoting	  the	  survival	  of	  existing	  ones.1	  It	  is	  
particularly	  active	  in	  the	  hippocampus,	  cortex,	  and	  basal	  forebrain.	  Its	  role	  in	  neurogenesis	  
suggests	  that	  BDNF	  is	  important	  in	  basic	  neural	  development	  and	  even	  may	  play	  a	  role	  in	  the	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formation	  of	  long	  term	  memory	  in	  the	  hippocampus.1	  Production	  of	  BDNF	  is	  exclusive	  to	  the	  
endoplasmic	  reticulum	  and	  an	  absence	  of	  adequate	  levels	  results	  in	  severe	  consequences,	  often	  
times	  proving	  lethal.	  The	  effect	  of	  physical	  activity	  on	  BDNF	  synthesis	  has	  shown	  a	  significant	  
positive	  correlation.	  In	  fact,	  certain	  aerobic	  exercise	  has	  been	  shown	  to	  consistently	  raise	  BDNF	  
levels	  in	  association	  with	  the	  level	  of	  physical	  activity.4	  In	  response	  to	  skeletal	  muscle	  




Erythropoietin	  (EPO)	  is	  one	  of	  the	  more	  well	  known	  cytokines	  that	  is	  responsible	  for	  
erythropoiesis	  with	  exercise.	  A	  primary	  role	  of	  EPO	  is	  to	  serve	  as	  a	  signaling	  molecule	  for	  red	  
blood	  cell	  that	  have	  not	  reached	  maturity	  in	  the	  bone	  marrow.	  EPO	  is	  predominately	  produced	  
in	  the	  kidneys	  by	  fibroblasts	  during	  adulthood	  and	  in	  the	  liver	  by	  peridinusoidal	  cells	  in	  the	  
perinatal	  period.22	  Without	  EPO,	  erythropoiesis	  does	  not	  take	  place	  as	  it	  is	  an	  essential	  
hormone	  for	  the	  process.	  Erythrocyte	  production	  and	  survival	  is	  promoted	  by	  EPO	  as	  it	  protects	  
these	  immature	  cells	  from	  apoptosis.22	  In	  a	  medical	  sense,	  EPO	  has	  commonly	  been	  used	  as	  a	  
therapy	  for	  certain	  types	  of	  anemia	  in	  an	  attempt	  to	  combat	  low	  red	  blood	  cell	  counts.	  EPO	  
production	  is	  vastly	  increased	  under	  hypoxic	  conditions,	  as	  erythrocytes	  are	  the	  body’s	  
mechanism	  for	  transporting	  oxygen.22	  During	  exercise,	  when	  the	  body	  is	  in	  a	  state	  of	  hypoxia	  
(low	  blood	  oxygen	  levels),	  EPO	  production	  may	  increase	  exponentially	  in	  an	  attempt	  to	  get	  
adequate	  oxygen	  for	  biological	  processes.	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Fatty	  Acid-­‐Binding	  Protein	  3	  
Fatty	  acid-­‐binding	  protein	  3	  (FABP3)	  is	  a	  member	  of	  the	  FABP	  family	  that	  is	  located	  
primarily	  in	  the	  muscle	  and	  the	  heart.	  FABP3	  is	  a	  relatively	  small	  protein	  that	  is	  originally	  
released	  from	  cardiac	  myocytes.	  It	  is	  involved	  in	  fatty	  acid	  metabolism	  and	  transports	  these	  
fatty	  acids	  into	  the	  mitochondria	  for	  oxidation.19	  A	  potential	  diagnostic	  use	  of	  FABP3	  is	  in	  the	  
prevention	  of	  myocardial	  infarctions,	  as	  it	  can	  be	  detected	  in	  the	  blood	  in	  the	  hours	  leading	  up	  
to	  the	  event.	  This	  results	  from	  detectable	  levels	  of	  FABP3	  being	  released	  into	  the	  circulation	  in	  
the	  event	  of	  myocardium	  injury.19	  When	  measured	  pre	  and	  post	  exercise,	  levels	  of	  FABP3	  were	  
found	  to	  increase	  in	  plasma	  samples	  in	  response	  to	  aerobic	  exercise.6	  
	  
Fibroblast	  Growth	  Factor	  21	  
Fibroblast	  Growth	  Factor	  21	  (FGF21)	  is	  a	  member	  of	  the	  fibroblast	  growth	  factor	  family	  
that	  are	  involved	  in	  a	  variety	  of	  biological	  processes	  such	  as	  embryonic	  development	  and	  tissue	  
repair.13	  Expression	  of	  the	  protein	  is	  found	  in	  the	  liver,	  adipose	  tissues,	  and	  the	  pancreas.	  
Glucose	  uptake	  stimulation	  in	  adipocytes	  is	  a	  function	  of	  FGF21	  and	  treatment	  of	  animals	  with	  
the	  protein	  resulted	  in	  increased	  energy	  expenditure	  and	  fat	  excretion.13	  Because	  of	  its	  role	  in	  
glucose	  uptake,	  it	  is	  claimed	  to	  have	  a	  great	  therapeutic	  potential	  for	  those	  with	  type	  2	  
diabetes.	  Although	  typically	  not	  expressed	  in	  skeletal	  muscle,	  there	  is	  evidence	  to	  support	  that	  
serum	  FGF21	  expression	  is	  increased	  after	  acute	  periods	  of	  exercise	  in	  animal	  and	  human	  
trials.13	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Follistatin-­‐related	  Protein	  1	  
Follistatin-­‐related	  protein	  1	  (FSTL1)	  is	  a	  protein	  that	  plays	  a	  role	  in	  development	  and	  is	  
encoded	  by	  the	  FSTL1	  gene.	  FSTL1	  plays	  a	  part	  in	  lung,	  ureter,	  central	  nervous	  system,	  and	  
skeletal	  development.3	  Inflammatory	  disorders	  such	  as	  arthritis	  also	  seem	  to	  be	  correlated	  with	  
an	  increased	  presence	  of	  FSTL1.	  Levels	  of	  FSTL1	  in	  the	  serum	  seem	  to	  be	  associated	  with	  the	  
up-­‐regulation	  of	  proinflammatory	  mediators	  that	  have	  significance	  in	  rheumatoid	  arthritis.15	  
Research	  has	  shown	  that	  the	  FSTL1	  myokine	  is	  secreted	  by	  myotubes	  in	  humans	  and	  that	  
plasma	  levels	  of	  FSTL1	  increase	  in	  response	  to	  exercise	  as	  well.3	  
	  
Fractalkine	  
Fractalkine,	  or	  CX3CL1,	  is	  a	  large	  cytokine	  protein	  consisting	  of	  373	  amino	  acids.	  It	  is	  
most	  commonly	  found	  throughout	  the	  brain	  in	  neural	  cells	  with	  its	  receptor	  found	  on	  microglial	  
cells.16	  Fractalkine	  is	  an	  essential	  component	  for	  microglial	  cell	  migration.	  Existing	  in	  two	  forms,	  
Fractalkine	  is	  believed	  to	  greatly	  enhance	  cell	  adhesion	  function	  in	  its	  membrane	  anchored	  
form	  and	  plays	  a	  role	  in	  attracting	  and	  activating	  natural	  killer	  (NK)	  cells,	  T	  cells,	  and	  monocytes,	  
which	  participate	  in	  the	  immune	  response	  and	  act	  against	  a	  variety	  of	  infected	  cells.28	  For	  this	  
reason,	  the	  immune	  recruitment	  function	  is	  being	  closely	  studied	  to	  determine	  its	  viability	  as	  a	  
treatment	  in	  pathological	  conditions.	  Upregulation	  of	  Fractalkine	  takes	  place	  in	  the	  
hippocampus	  briefly	  following	  spatial	  learning,	  and	  neuroprotective	  effects	  have	  also	  been	  
observed	  in	  the	  inhibition	  of	  microglial	  activation.16	  Fractalkine	  increases	  the	  expression	  of	  pro-­‐
inflammatory	  factors	  in	  human	  myoblasts	  and	  myotubes	  in	  skeletal	  muscle.	  According	  to	  recent	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research,	  Fractalkine	  mRNA	  and	  protein	  level	  in	  the	  skeletal	  muscle	  has	  been	  shown	  to	  increase	  
after	  one	  bout	  of	  exercise.28	  
	  
Interleukin	  6	  
Interleukin	  6	  (IL6)	  is	  another	  protein	  that	  acts	  as	  both	  a	  pro-­‐inflammatory	  and	  anti-­‐
inflammatory	  cytokine.7	  Interleukin	  6	  is	  encoded	  by	  the	  IL6	  gene	  and	  is	  secreted	  by	  T	  cells	  to	  
enact	  an	  immune	  response,	  often	  resulting	  in	  inflammation.	  IL6	  also	  participates	  in	  osteoclast	  
formation	  when	  excreted	  by	  osteoblasts,	  and	  when	  produced	  by	  blood	  vessels,	  it	  behaves	  as	  a	  
pro-­‐inflammatory	  cytokine.7	  Other	  capabilities	  include	  crossing	  the	  blood-­‐brain	  barrier	  to	  
initiate	  the	  synthesis	  of	  prostaglandin	  and	  stimulating	  protein	  synthesis7,	  in	  addition	  to	  its	  
function	  as	  a	  myokine.	  As	  a	  myokine,	  IL6	  levels	  are	  elevated	  in	  response	  to	  skeletal	  muscle	  
contraction,	  and	  was	  the	  first	  myokine	  to	  be	  reported	  to	  be	  secreted	  into	  the	  blood	  stream	  in	  
response	  to	  exercise7.	  Studies	  have	  shown	  that	  the	  magnitude	  of	  IL6	  response	  is	  dependent	  on	  
duration	  and	  intensity	  of	  exercise,	  while	  the	  method	  of	  exercise	  exhibited	  little	  effect.	  	  
	  
Interleukin	  15	  
Interleukin	  15	  (IL15)	  is	  a	  cytokine	  belonging	  to	  a	  superfamily	  of	  similarly	  structured	  
proteins	  differentiated	  by	  their	  number.	  IL15	  is	  expressed	  in	  a	  variety	  of	  different	  cells	  including	  
macrophages,	  fibroblasts,	  and	  nerve	  cells.24	  Upon	  discovery,	  it	  was	  determined	  that	  IL15	  plays	  
an	  important	  role	  in	  immunity	  as	  a	  T	  cell	  growth	  factor.	  Immune	  regulation	  is	  mainly	  
characterized	  by	  activation	  and	  propagation	  of	  NK	  and	  T	  cells	  by	  inducing	  apoptosis	  inhibitor.24	  
During	  muscle	  contraction,	  IL15	  is	  produced	  in	  an	  attempt	  to	  mediate	  the	  effects	  of	  exercise	  on	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muscle	  metabolism.	  It	  is	  regarded	  as	  having	  an	  anti-­‐inflammatory	  effect	  in	  the	  muscle	  tissue	  in	  
an	  attempt	  to	  maintain	  muscle	  homeostasis.	  
	  
Irisin	  
Fibronectin	  type	  III	  domain-­‐containing	  protein	  5	  is	  the	  precursor	  of	  Irisin	  and	  is	  encoded	  
by	  the	  FNDC5	  gene.	  Irisin	  production	  is	  stimulated	  by	  the	  increased	  expression	  of	  PGC-­‐1alpha,	  
which	  is	  believed	  to	  aid	  in	  adaptation	  to	  exercise.12	  Since	  Irisin	  production	  is	  involved	  in	  a	  
mechanism	  that	  begins	  with	  a	  muscular	  contraction,	  it	  is	  classified	  as	  a	  myokine.	  It	  has	  been	  
recently	  debated,	  however,	  whether	  or	  not	  Irisin	  is	  circulated	  in	  detectable	  amounts	  in	  the	  
blood,	  but	  the	  most	  recent	  research	  seems	  to	  indicate	  that	  it	  is	  secreted	  by	  skeletal	  muscle	  and	  
plays	  an	  important	  role	  in	  the	  homeostasis	  of	  energy	  balance,	  indicating	  that	  Irisin	  does	  indeed	  
circulate	  at	  nanogram	  levels	  and	  increases	  with	  exercise.12	  After	  participating	  in	  resistance	  
exercise,	  circulating	  Irisin	  levels	  have	  been	  shown	  to	  increase	  in	  both	  mouse	  models	  and	  human	  
studies.12	  
	  
Leukemia	  Inhibitory	  Factor	  
Leukemia	  inhibitory	  factor	  (LIF)	  has	  a	  function,	  quite	  literally,	  that	  leads	  to	  the	  
prevention	  of	  leukemic	  cell	  growth.	  It	  accomplishes	  this	  by	  inducing	  terminal	  differentiation	  of	  
these	  cells,	  thus	  ending	  their	  proliferation.2	  In	  addition	  to	  its	  primary	  function,	  it	  is	  also	  
responsible	  for	  certain	  types	  of	  cell	  differentiation	  and	  cell	  growth.	  Bone	  metabolism,	  
inflammation,	  and	  neural	  development	  are	  other	  areas	  where	  LIF	  exhibits	  promotion	  of	  
growth.2	  During	  exercise,	  there	  is	  an	  up-­‐regulation	  of	  LIF	  in	  skeletal	  muscle;	  however,	  LIF	  levels	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in	  the	  circulation	  do	  not	  increase,	  indicating	  that	  LIF	  may	  have	  an	  autocrine	  effect	  within	  the	  
muscle	  tissue.	  Based	  on	  its	  cell	  proliferation	  function,	  there	  is	  evidence	  to	  support	  that	  LIF	  may	  
be	  produced	  by	  the	  skeletal	  muscle	  in	  response	  to	  exercise	  to	  contribute	  to	  muscle	  adaptation.2	  
	  
Musclin	  
Musclin,	  also	  known	  as	  Osteocrin	  (OSTN)	  is	  a	  human	  myokine	  that	  is	  expressed	  in	  
skeletal	  tissue,	  primarily	  in	  osteoblasts,	  which	  suggests	  a	  role	  in	  bone	  formation.	  Through	  a	  
single	  fiber	  analysis,	  it	  was	  also	  found	  that	  Musclin	  is	  produced	  by	  type	  IIb	  muscle	  fibers.26	  
Musclin	  has	  been	  considered	  an	  exercise-­‐responsive	  myokine	  vital	  to	  skeletal	  muscle	  
adaptation	  during	  exercise.	  Through	  the	  use	  of	  Musclin-­‐encoding	  gene	  knockout	  mice,	  it	  was	  
found	  that	  elimination	  of	  OSTN	  significantly	  lowered	  maximum	  aerobic	  capacity	  and	  
mitochondrial	  protein	  content.26	  This	  suggests	  that	  Musclin	  enhances	  physical	  endurance	  
through	  the	  promotion	  of	  mitochondrial	  biogenesis.	  
	  
Myostatin	  
Myostatin	  (GDF8)	  is	  a	  relatively	  well	  known	  myokine	  whose	  function	  is	  to	  inhibit	  
myogenesis	  (muscle	  growth).	  Acting	  as	  a	  key	  signaling	  molecule,	  Myostatin	  signals	  the	  
dormancy	  of	  satellite	  cells,	  therefore	  inhibiting	  growth	  and	  differentiation	  of	  myoblasts.	  It	  is	  
encoded	  by	  the	  MSTN	  gene	  and	  is	  produced	  and	  released	  by	  myocytes.9,	  18	  Myostatin	  is	  found	  
almost	  exclusively	  in	  the	  skeletal	  muscle,	  with	  a	  small	  amount	  being	  located	  in	  the	  blood.18	  
Myostatin	  is	  active	  before	  and	  after	  birth,	  playing	  a	  part	  in	  muscle	  development	  and	  preventing	  
excess	  muscle	  growth.9	  Lack	  of	  the	  MTSN	  gene	  or	  the	  blocking	  of	  Myostatin	  activity	  results	  in	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the	  formation	  of	  significantly	  more	  muscle	  mass.	  This	  is	  a	  genetic	  abnormality	  that	  may	  occur	  in	  
animals	  but	  also	  may	  be	  able	  to	  serve	  a	  therapeutic	  purpose	  as	  a	  treatment	  of	  muscle	  wasting	  
diseases,	  although	  further	  research	  is	  needed.	  In	  response	  to	  aerobic	  exercise,	  it	  was	  found	  that	  
Myostatin	  levels	  in	  both	  muscle	  and	  plasma	  samples	  decrease,	  compared	  to	  rest.9	  	  
	  
Oncostatin	  M	  
Oncostatin	  M	  (OSM)	  is	  a	  cytokine	  encoded	  by	  the	  OSM	  gene	  that	  belongs	  to	  the	  
Interleukin	  family	  of	  cytokines.	  The	  function	  of	  OSM	  splits	  into	  two	  schools	  of	  thought:	  as	  a	  pro-­‐
inflammatory	  protein	  and	  as	  an	  anti-­‐inflammatory	  protein.17,	  29	  The	  pro-­‐inflammatory	  role	  is	  
suggested	  by	  the	  effect	  of	  OSM	  on	  endothelial	  cells,	  as	  it	  may	  induce	  an	  inflammatory	  
response.17	  Anti-­‐inflammatory	  properties	  have	  also	  been	  observed	  as	  OSM	  effectively	  
suppressed	  inflammation	  and	  destruction	  of	  tissue	  in	  animal	  models	  of	  chronic	  inflammatory	  
diseases.29	  Serum	  and	  muscle	  samples	  taken	  after	  an	  exercise	  bout	  appeared	  to	  exhibit	  an	  
increase	  in	  OSM	  levels,	  with	  significant	  upregulation	  taking	  place.17	  Typically,	  OSM	  is	  




Osteonectin,	  also	  known	  as	  secreted	  protein	  acidic	  and	  rich	  in	  cysteine	  (SPARC),	  is	  a	  
glycoprotein	  located	  in	  the	  bone	  that	  binds	  calcium	  and	  is	  encoded	  by	  the	  SPARC	  gene.11	  
Several	  biological	  functions	  have	  been	  attributed	  to	  osteonectin	  such	  as	  bone	  and	  cartilage	  
mineralization,	  as	  well	  as	  collagen	  binding.	  Elevated	  levels	  of	  osteonectin	  are	  also	  beneficial	  to	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tumor	  growth,	  and	  overexpression	  has	  been	  reported	  in	  several	  types	  of	  cancer	  as	  it	  aids	  in	  cell	  
attachment	  and	  proliferation.11	  There	  have	  been	  numerous	  studies	  indicating	  that	  the	  presence	  
of	  Osteonectin	  in	  various	  tissues	  indicate	  a	  regenerative	  function.	  Osteonectin	  has	  often	  been	  
expressed	  during	  repair	  periods	  including	  expression	  in	  response	  to	  muscle	  damage.	  
Osteonectin	  has	  also	  been	  found	  to	  be	  present	  in	  neonatal	  muscle	  cells.11	  This,	  in	  addition	  to	  its	  
regenerative	  properties	  indicates	  a	  role	  in	  early	  muscle	  development	  as	  well	  as	  reformation,	  as	  
the	  cytokine	  is	  found	  in	  satellite	  cells	  as	  well	  as	  the	  muscle	  fibers	  themselves.11	  
	  
Materials	  and	  Methods	  
Subjects	  and	  Baseline	  Testing	  
	   The	  purpose	  of	  this	  study	  was	  to	  investigate	  the	  myokine	  response	  to	  prolonged	  
exercise.	  The	  samples	  analyzed	  in	  this	  pilot	  investigation	  were	  obtained	  from	  a	  previously	  
performed	  study	  (IRB	  #14-­‐0173),	  whereby	  skeletal	  muscle	  biopsy	  samples	  were	  collected	  from	  
trained	  cyclists	  before	  and	  immediately	  after	  performing	  a	  75-­‐km	  cycling	  exercise	  bout.	  The	  
participants	  were	  14	  male	  cyclists	  (age	  38.5	  ±	  9.3	  years)	  who	  regularly	  raced	  and	  were	  familiar	  
with	  long	  distance	  cycling	  bouts.	  	  
One	  week	  before	  the	  75-­‐km	  cycling	  session,	  each	  cyclist	  underwent	  orientation	  and	  
baseline	  testing.	  The	  orientation	  consisted	  of	  questionnaires	  to	  determine	  demographic	  
information	  and	  training	  history.	  A	  graded	  exercise	  test	  was	  used	  to	  determine	  maximal	  power,	  
heart	  rate,	  ventilation,	  and	  maximum	  oxygen	  consumption.	  This	  test	  began	  at	  150	  watts	  and	  a	  
25	  watt	  increase	  occurred	  every	  two	  minutes.	  The	  test	  was	  performed	  using	  the	  Cosmed	  Quark	  
CPET	  metabolic	  cart	  (Rome,	  Italy)	  and	  the	  LODE	  cycle	  ergometer	  (Lode	  Excaliber	  Sport,	  Lode	  
	   	   Tolbert	  |	  13	  
	  
B.V.,	  Groningen,	  Netherlands).	  Body	  composition	  was	  also	  measured	  using	  the	  Bod	  Pod	  body	  
composition	  analyzer	  (Life	  Measurement,	  Concord,	  CA).	  
	  
75-­‐km	  Cycling	  Time	  Trial	  
	   A	  week	  after	  the	  initial	  baseline	  testing,	  subjects	  participated	  in	  the	  75-­‐km	  cycling	  
exercise	  bout	  using	  their	  own	  bicycles	  which	  were	  mounted	  on	  CompuTrainer	  Pro	  Model	  8001	  
trainers	  (Racermate,	  Seattle,	  WA).	  Using	  the	  software,	  a	  mountainous	  75-­‐km	  course	  of	  
moderate	  difficulty	  was	  selected	  and	  programmed	  into	  the	  system.	  Both	  heart	  rate	  and	  rating	  
of	  perceived	  exertion	  (RPE)	  were	  recording	  after	  the	  first	  15	  minutes,	  and	  for	  every	  60	  minutes	  
following.	  Workload	  in	  watts	  was	  also	  monitored	  continuously	  using	  the	  CompuTrainer	  
MultiRider	  software	  system	  (version	  3.0).	  Ventilation	  and	  oxygen	  consumption	  were	  measured	  
after	  16	  km	  and	  55km	  using	  the	  metabolic	  cart.	  Subjects	  were	  only	  allowed	  to	  consume	  water	  
during	  the	  trial.	  	  
	  
Muscle	  Biopsy	  Analysis	  
	   Pre-­‐	  and	  post-­‐	  exercise	  muscle	  biopsy	  samples	  were	  acquired	  from	  the	  vastus	  lateralis	  of	  
the	  same	  leg	  at	  locations	  roughly	  2	  cm	  apart.	  A	  local	  anesthetic	  (1%	  xylocaine,	  Hospira,	  Inc.,	  
Lake	  Forest,	  IL)	  was	  injected	  subcutaneously.	  The	  muscle	  biopsy	  sample	  was	  obtained	  using	  the	  
suction-­‐modified	  percutaneous	  needle	  biopsy	  procedure.25	  The	  muscle	  samples	  were	  trimmed	  
of	  fat	  and	  connective	  tissue	  and	  immediately	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C	  until	  
analysis	  took	  place.	  	   	  
The	  skeletal	  muscle	  biopsy	  samples	  were	  analyzed	  for	  15	  myokines	  including:	  APLN,	  
CX3CL1,	  BDNF,	  EPO,	  SPARC,	  LIF,	  IL15,	  GDF8,	  FABP3,	  Irisin,	  FSTL1,	  OSM,	  IL6,	  FGF21,	  and	  OSTN.	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These	  myokines	  were	  analyzed	  with	  a	  magnetic	  bead-­‐based	  multiplex	  assay	  (MILLIPLEX®	  map	  
Human	  Myokine	  Panel)	  using	  the	  MAGPIX	  instrument	  and	  MILLIPLEX®	  Analyst	  Software	  
(version	  5.1).	  Briefly,	  ~30	  mg	  of	  each	  skeletal	  muscle	  tissue	  biopsy	  sample	  was	  homogenized	  in	  
lysis	  buffer	  (Millipore,	  Billerica,	  MA;	  #43-­‐040)	  with	  AEBSF	  protease	  inhibitor	  added	  (Millipore;	  
#101500).	  	  Next,	  81.25	  µg	  of	  muscle	  protein	  was	  added	  to	  each	  well	  (in	  duplicate)	  and	  the	  
concentration	  of	  each	  myokine	  was	  measured	  using	  the	  MILLIPLEX®	  map	  assay	  kit	  (Millipore,	  
HMYOMAG-­‐56K)	  following	  the	  manufacturer’s	  specifications.	  The	  lower	  limit	  of	  detection	  for	  
this	  panel	  of	  analytes	  was:	  APLN	  =	  11.11	  pg/mL;	  BDNF	  =	  0.040	  pg/mL;	  EPO	  =	  123.81	  pg/mL;	  
FABP3	  =	  2.51	  pg/mL;	  FGF21	  =	  1.22	  pg/mL;	  FSTL1	  =	  0.045	  ng/mL;	  CX3CL1	  =	  20.36	  pg/mL;	  IL-­‐6	  =	  
0.087	  pg/mL;	  IL-­‐15	  =	  0.12	  pg/mL;	  Irisin	  =	  190.05	  pg/mL;	  LIF	  =	  0.75	  pg/mL;	  OSTN	  =	  8.93	  pg/mL;	  
GDF8	  =	  0.25	  ng/mL;	  OSM	  =	  0.010	  pg/mL;	  SPARC	  =	  84.03	  pg/mL;	  
	  
Statistical	  Analysis	  
	   Data	  are	  expressed	  as	  mean±SD.	  Change	  between	  pre-­‐	  and	  post-­‐	  exercise	  
measurements	  were	  tested	  for	  change	  using	  a	  paired	  t-­‐tests,	  with	  alpha	  level	  P≤0.05.	  Several	  
transformations	  had	  to	  be	  performed	  in	  order	  for	  some	  of	  the	  data	  to	  be	  normalized.	  The	  log	  of	  
the	  FGF21	  results	  was	  taken	  and	  the	  square	  root	  of	  the	  log	  of	  OSTN	  was	  taken	  in	  order	  to	  
obtain	  results.	  In	  addition,	  LIF	  data	  had	  to	  be	  analyzed	  sans	  subject	  9,	  as	  this	  determined	  to	  be	  
an	  outlier,	  based	  on	  the	  values	  being	  +2	  SD	  from	  the	  mean.	  All	  statistical	  analysis	  was	  
performed	  using	  SigmaPlot	  software	  (version	  12.5,	  Systat	  Software,	  Inc.).	  	  
Results	  
	   The	  75km	  cycling	  exercise	  bout	  significantly	  increased	  skeletal	  muscle	  Interleukin-­‐15,	  
Oncostatin	  M,	  and	  Fractalkine	  protein	  levels	  from,	  0.043±0.008	  to	  0.055±0.021,	  0.0014±0.002	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to	  0.0059±0.004	  and	  4.45±0.46	  to	  4.60±0.54	  pg/µg,	  respectively	  (all	  p<0.05;	  Figures	  3,	  4,	  and	  8).	  
Apelin	  protein	  levels	  exhibited	  a	  decrease	  from	  3.95±1.18	  to	  3.33±1.21	  pg/µg	  (p<0.05;	  Figure	  
1).	  No	  statistically	  significant	  difference	  was	  observed	  for	  FSTL1,	  IL6,	  SPARC,	  BDNF,	  FGF21,	  LIF,	  
or	  OSTN	  (Figures	  2,	  5,	  6,	  7,	  9,	  10,	  and	  11).	  Erythropoietin,	  Irisin,	  and	  Myostatin	  were	  all	  below	  
detectable	  limits	  for	  the	  assay,	  and	  Fatty	  Acid-­‐Binding	  Protein	  3	  exhibited	  values	  above	  the	  
detection	  limit.	  	  
	  
Discussion	  
	   There	  seemed	  to	  be	  a	  large	  amount	  of	  variation	  between	  the	  different	  participants	  for	  
many	  of	  the	  myokines	  tested.	  This	  is	  indicated	  by	  the	  large	  amount	  of	  overlap	  in	  the	  standard	  
deviations	  between	  the	  pre-­‐	  and	  post-­‐	  measurements.	  Because	  of	  this	  large	  amount	  of	  
variation,	  it	  is	  possible	  that	  the	  participants	  were	  at	  different	  levels	  of	  fitness	  for	  the	  testing	  
period,	  even	  though	  they	  were	  all	  considered	  trained.	  This	  is	  especially	  true	  of	  subject	  number	  
9,	  whose	  data	  seems	  exaggerated	  when	  compared	  to	  most	  of	  the	  other	  athletes.	  For	  example,	  
a	  mean	  decrease	  of	  50	  pg/mL	  Apelin	  protein	  was	  observed	  for	  the	  group,	  however,	  subject	  9	  
actually	  exhibited	  an	  increase	  of	  106	  pg/mL.	  This	  large	  difference	  is	  also	  why	  subject	  9	  was	  
excluded	  in	  the	  data	  analysis	  for	  Leukemia	  Inhibitory	  Factor.	  	  
	   Despite	  the	  variations,	  four	  myokines	  (Fractalkine,	  Oncostatin	  M,	  Interleukin	  15,	  and	  
Apelin)	  exhibited	  a	  significant	  difference	  between	  pre-­‐	  and	  post-­‐exercise	  samples.	  Of	  the	  
remaining	  myokines,	  Interleukin-­‐6	  and	  Osteocrin	  were	  very	  close	  to	  exhibiting	  significant	  
results,	  with	  P-­‐values	  of	  0.059	  for	  both.	  Unfortunately,	  levels	  of	  Erythropoietin,	  Myostatin,	  and	  
Irisin	  were	  below	  detectable	  levels,	  suggesting	  that	  these	  cytokines	  do	  not	  have	  a	  substantial	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presence	  in	  the	  muscle	  tissue	  itself.	  This	  is	  unsurprising	  for	  Irisin,	  as	  it	  is	  still	  being	  actively	  
debated	  whether	  or	  not	  there	  is	  any	  detectable	  amount	  in	  human	  skeletal	  tissue.	  In	  the	  case	  of	  
GDF8,	  data	  has	  indicated	  that	  levels	  drop	  after	  aerobic	  exercise,	  making	  it	  unlikely	  that	  already	  
low	  levels	  would	  rise	  into	  the	  detectable	  range	  post-­‐	  exercise.	  EPO	  levels	  were	  all	  over	  the	  
board	  with	  several	  being	  in	  the	  detectable	  range	  but	  most	  being	  below	  the	  readable	  limit.	  
Erythropoietin	  is	  produced	  by	  the	  kidneys	  and	  secreted	  into	  the	  blood;	  so	  one	  possible	  
explanation	  could	  be	  that	  there	  was	  blood	  contamination	  in	  some	  of	  the	  muscle	  biopsy	  
samples.	  	  	  
	  
Conclusion	  
	   	  Over	  the	  last	  couple	  decades,	  our	  knowledge	  of	  cytokine	  proteins	  has	  increased	  
considerably	  as	  has	  our	  understanding	  of	  their	  functions	  and	  regulatory	  mechanisms.	  However,	  
with	  few	  exceptions,	  our	  knowledge	  is	  still	  relatively	  limited	  as	  to	  the	  mechanism	  and	  
regulation	  of	  cytokine	  production	  during	  exercise,	  especially	  in	  the	  muscle	  tissue.	  Consequently,	  
research	  is	  still	  ongoing	  for	  many	  of	  the	  tested	  proteins	  to	  determine	  their	  function	  when	  it	  
comes	  to	  skeletal	  muscle	  adaptation.	  Because	  of	  the	  sizeable	  variation	  between	  subjects	  and	  
several	  of	  the	  proteins	  being	  outside	  of	  the	  detection	  limit,	  only	  four	  of	  the	  15	  cytokines	  
exhibited	  a	  statistically	  significant	  difference	  from	  pre-­‐to	  post-­‐exercise.	  Of	  these	  four,	  CX3CL1,	  
OSM,	  and	  IL15	  showed	  an	  increase	  and	  APLN	  showed	  a	  decrease	  in	  protein	  concentration	  in	  
response	  to	  a	  75-­‐km	  cycling	  exercise	  stimulus.	  	  
	  
	  




Figure	  1:	  Concentration	  of	  APLN	  in	  the	  skeletal	  muscle	  before	  and	  after	  exercise	  (asterisk	  
indicates	  statistically	  significant	  decrease)	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Figure	  3:	  Concentration	  of	  IL15	  in	  the	  skeletal	  muscle	  before	  and	  after	  exercise	  (asterisk	  




Figure	  4:	  Concentration	  of	  OSM	  in	  the	  skeletal	  muscle	  before	  and	  after	  exercise	  (asterisk	  
indicates	  statistically	  significant	  increase)	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Figure	  5:	  Concentration	  of	  IL6	  in	  the	  skeletal	  muscle	  before	  and	  after	  exercise	  
	  
	  
Figure	  6:	  Concentration	  of	  SPARC	  in	  the	  skeletal	  muscle	  before	  and	  after	  exercise	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Figure	  8:	  Concentration	  of	  CX3CL1	  in	  the	  skeletal	  muscle	  before	  and	  after	  exercise	  (asterisk	  
indicates	  statistically	  significant	  increase)	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Figure	  10:	  Concentration	  of	  LIF	  in	  the	  skeletal	  muscle	  before	  and	  after	  exercise	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